These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9569416)

  • 1. Preventing RhD haemolytic disease of the newborn. RhD negative women who have intrauterine death may need anti-D immunoglobulin.
    Fox R
    BMJ; 1998 Apr; 316(7138):1164-5. PubMed ID: 9569416
    [No Abstract]   [Full Text] [Related]  

  • 2. Routine administration of Anti-D: the ethical case for offering pregnant women fetal RHD genotyping and a review of policy and practice.
    Kent J; Farrell AM; Soothill P
    BMC Pregnancy Childbirth; 2014 Feb; 14():87. PubMed ID: 24568571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventing RhD haemolytic disease of the newborn. Women should be counselled about source of anti-D immunoglobulin.
    Saha A
    BMJ; 1998 Apr; 316(7138):1165. PubMed ID: 9569418
    [No Abstract]   [Full Text] [Related]  

  • 4. Preventing RhD haemolytic disease of the newborn. Revised guidelines advocate two doses of anti-D immunoglobulin for antenatal prophylaxis.
    Lee D
    BMJ; 1998 May; 316(7144):1611. PubMed ID: 9596614
    [No Abstract]   [Full Text] [Related]  

  • 5. Preventing RhD haemolytic disease of the newborn. Guidelines are not followed in many cases.
    McFadyen IR; Martlew VJ; Howard HL; Clarke CA
    BMJ; 1998 Apr; 316(7138):1165. PubMed ID: 9569417
    [No Abstract]   [Full Text] [Related]  

  • 6. Preventing RhD haemolytic disease of the newborn. Services should be centralised for pregnancies affected by RhD haemolytic disease.
    Craig JS; McClure BG; Tubman TR
    BMJ; 1998 May; 316(7144):1611. PubMed ID: 9616034
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hemolytic disease of the newborn has not vanished from Finland--routine protection of RhD negative mothers during pregnancy is justifiable].
    Sainio S; Kuosmanen M
    Duodecim; 2012; 128(2):151-7. PubMed ID: 22372070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventing RhD haemolytic disease of the newborn.
    van Dijk B
    BMJ; 1997 Dec; 315(7121):1480-1. PubMed ID: 9420481
    [No Abstract]   [Full Text] [Related]  

  • 9. Fetal RhD genotyping: a more efficient use of anti-D immunoglobulin.
    Daniels G; Finning K; Martin P; Summers J
    Transfus Clin Biol; 2007 Dec; 14(6):568-71. PubMed ID: 18436463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An increased risk for non allo-immunization related intrauterine fetal death in RhD-negative patients.
    Ben-David G; Sheiner E; Levy A; Erez O; Mazor M
    J Matern Fetal Neonatal Med; 2008 Apr; 21(4):255-9. PubMed ID: 18330822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preventing RhD haemolytic disease of the newborn. New recommendations must be explained to GPs and midwives.
    Everett C; Wray J
    BMJ; 1998 Apr; 316(7138):1165. PubMed ID: 9569419
    [No Abstract]   [Full Text] [Related]  

  • 12. [The importance of antenatal immunoprophylaxis for prevention of hemolytic disease of the fetus and newborn].
    Starcević M; Mataija M; Sović D; Dodig J; Matijević R; Kukuruzović M
    Acta Med Croatica; 2011 Mar; 65(1):49-54. PubMed ID: 21568074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventing rhesus D haemolytic disease of the newborn by giving anti-D immunoglobulin: are the guidelines being adequately followed?
    Harding K
    Br J Obstet Gynaecol; 1997 Jul; 104(7):869-70. PubMed ID: 9236664
    [No Abstract]   [Full Text] [Related]  

  • 14. RhIg for the prevention Rh immunization and IVIg for the treatment of affected neonates.
    Legler TJ
    Transfus Apher Sci; 2020 Oct; 59(5):102950. PubMed ID: 33004277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevention of fetomaternal rhesus-D allo-immunization. Practical aspects].
    Cortey A; Brossard Y
    J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S123-1S130. PubMed ID: 16495838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Guideline for prevention of RhD alloimmunizationin RhD negative women].
    Lubušký M; Procházka M; Simetka O; Holusková I
    Ceska Gynekol; 2013 Apr; 78(2):132-3. PubMed ID: 23710977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receipt of RhD-positive whole blood for life-threatening bleeding in female children: A survey in alloimmunized mothers regarding minimum acceptable survival benefit relative to risk of maternal alloimmunization to anti-D.
    Sherwood MR; Clayton S; Leeper CM; Yazer M; Moise KJ; Granger ME; Spinella PC
    Transfusion; 2024 May; 64 Suppl 2():S100-S110. PubMed ID: 38563495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Spontaneous antepartal RhD alloimmunization].
    Studničková M; Holusková I; Durdová V; Kratochvílová T; Strašilová P; Marková I; Lubušký M
    Ceska Gynekol; 2015 Dec; 80(6):401-4. PubMed ID: 26741153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolated early onset anemia after rh isoimmunization: a unique presentation in 3 neonates.
    Louis D; Oberoi S; Sundaram V; Trehan A
    J Pediatr Hematol Oncol; 2010 Aug; 32(6):e230-2. PubMed ID: 20628321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RhD hemolytic disease of the newborn.
    Bowman JM
    N Engl J Med; 1998 Dec; 339(24):1775-7. PubMed ID: 9845715
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.